Aarti Surfactants Limited Holds 8th AGM, Shares Investor Presentation
Aarti Surfactants Limited held its 8th AGM on September 29, 2026, presenting investor updates. For FY2026, operational revenue rose 30% to ₹85,912.92 Lakhs. However, EBITDA decreased 5% to ₹4,731.80 Lakhs and PAT fell 15% to ₹1,267.83 Lakhs. The company also secured a credit rating upgrade to CRISIL A-/Stable.
The announcement provides an update on the AGM and financial performance, including a significant revenue jump and a credit rating upgrade. While profitability has declined, the overall information is material for investors tracking the company's performance and creditworthiness, warranting a medium impact.
The announcement reports a significant revenue increase but also a decline in profitability metrics like EBITDA and PAT. The credit rating upgrade is positive, but the overall financial performance shows mixed results, leading to a neutral sentiment.
Aarti Surfactants Limited announced the conclusion of its 8th Annual General Meeting (AGM) held on Tuesday, September 29, 2026. The company has submitted a presentation made to its shareholders during the AGM, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The presentation highlights the company's journey since its incorporation in 2018 following the demerger from Aarti Industries Limited. It details Aarti Surfactants' specialization in manufacturing high-performance ionic, non-ionic, and specialty surfactants for both domestic and international markets, with a strategic focus on the high-margin skincare segment. The company operates two manufacturing units in Madhya Pradesh and Silvassa, supported by a dedicated R&D center in Navi Mumbai. ASL boasts a global export presence across Asia, Europe, Africa, and the Americas, serving over 100 customers in more than 50 countries.
Financially, for FY2026, Aarti Surfactants reported operational revenue of ₹85,912.92 Lakhs, a 30% year-on-year increase from FY2025's ₹65,908.54 Lakhs. However, EBITDA saw a marginal decrease of 5% to ₹4,731.80 Lakhs from ₹4,981.54 Lakhs in FY2025, with the EBITDA margin declining from 7.56% to 5.51%. Profit After Tax (PAT) for FY2026 stood at ₹1,267.83 Lakhs, a 15% decrease from ₹1,499.00 Lakhs in FY2025, resulting in a PAT margin of 1.48% compared to 2.27% in the previous year. Diluted EPS also decreased by 16% to ₹14.96 from ₹17.71.
The company also noted a credit rating upgrade, with its long-term bank facilities being revised to CRISIL A-/Stable from CARE BBB+/Stable by CRISIL Ratings in September 2026. This upgrade reflects the company's evolving financial standing and market position.
What to do with a filing like this
Aarti Surfactants Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aarti Surfactants Limited. Read the original for the full detail.